Protection by cyclosporine a against normothermic liver ischemia- reperfusion in pigs

Journal of Surgical Research

Volumn 75, Issue 2, 1998, Pages 116-126

  Travis, Denise L ^a   Fabia, Renata ^a   Netto, George G ^a   Husberg, Bo S ^a   Goldstein, Robert M ^a   Klintmalm, Goran B ^a   Levy, Marlon F ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclosporine A; Ischemia reperfusion injury; Liver perfusion

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HISTOPATHOLOGY; LIVER BLOOD FLOW; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; TREATMENT OUTCOME;

EID: 0031799817     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5297     Document Type: Article

References (27)

1. Starzl, T. E. Iwatsuki, S. Klintmalm, G. Schroter, G. P. J. Weil, III, R. Koep, L. J. Porter, K. A. Liver transplantation, 1980, with particular reference to cyclosporin-a, Transplant. Proc. 13, 281.
2. Caine R. Impact of immunosuppressants on host tissue and tolerance. Transplant. Proc. 26:1994;3065.
3. Simmons R. L., Wang S. C. New horizons in immunosuppression. Transplant. Proc. 23:1991;2152.
4. Tatsuma T., Kim Y. I., Ono M., Kai T., Ishii T., Akizuki S., Kobayashi M. Suppression of superoxide production from polymorphonuclear leukocytes by cyclosporine in ischemia-reperfusion of the liver. Transplant. Proc. 26:1994;2413.
5. +. Biochem. J. 255:1988;357.
6. Suzuki S., Toledo-Pereyra L. H., Rodriguez F. J., Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation. 56:1993;1265.
7. Thomson A. W., Moon D. K., Geczy C. L., Nelson D. S. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology. 48:1983;291.
8. Goto S., Kim Y. L., Shimada T., Kawano K., Kobayashi M. The effects of pretransplant cyclosporine therapy on rats grafted with twelve-hour cold-stored livers - with special reference to reperfusion injury. Transplantation. 52:1991;615.
9. Benson A., Ziegler H. K. Macrophages as targets for inhibition by cyclosporine. Transplantation. 47:1989;696.
10. Kurokawa T., Kobayashi H., Nonami T., Harada A., Nakao A., Sugiyama S., Ozawa T., Taragi H. Beneficial effects of cyclosporine on postischemic liver injury in rats. Transplantation. 53:1992;308.
11. Kubes P., Hunter J., Granger D. N. Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat. Dig. Dis. Sci. 36:1991;1469.
12. Clavien P. A., Harvey P. R., Strasberg S. M. Preservation and reperfusion injuries and liver allografts: an overview and synthesis of current studies. Transplantation. 53:1992;957.
13. Emre S., Schwartz M. E., Katz E., Miller C. M. Liver resection under total vascular isolation: Variations on a theme. Ann. Surg. 217:1993;15.
14. Kim Y. I., Kawano K., Nakashima K., Goto S., Kobayashi M. Alleviation of 3. Transplantation. 51:1991;731.
15. Broekemeier K. M., Dempsey M. E., Pfeiffer D. R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264:1989;7826.
16. Kawano K., Kim Y. I., Kaketani K., Kobayashi M. The beneficial effect of cyclosporine on liver ischemia in rats. Transplantation. 48:1989;759.
17. Paulsen A. W., Travis D. L. Experimental liver transplantation in large animals. Transplantation of the Liver. 1996;Saunders Co, Philadelphia. p. 33-42.
18. Nishiyama R., Nakamura S., Suzuki S., Baba S. Platelet-activating factor in hepatic ischemia/reperfusion injury. Transplantation. 55:1993;1261.
19. Helling T. S., Hacker K. A., Kragel P. J., Eisenstein C. L. Evidence for cytoprotection by prostaglandin E1 with normothermic hepatic ischemia. J. Surg. Res. 56:1994;309.
20. Fukuzawa K., Emre S., Senyuz O., Acarli K., Schwartz M. E., Miller C. M. N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation. 59:1995;6.
21. Kawano K., Kim Y. I., Ono M., Goto S., Kai T., Kobayashi M. Evidence that both cyclosporin and azathioprine prevent ischemia reperfusion injury to the rat liver. Transpl. Int. 6:1993;330.
22. Duncan J. R., Prasse K. W. Hepatic laboratory tests. Veterinary Laboratory Medicine Clinical Pathology. 1986;Iowa State Univ. Press, Ames. p. 123-127.
23. Hardy K. J., Tancheroen S., Shulkes A. Premedication with cyclosporine and perindopril modifies the ischemia-reperfusion injury during liver resection in the rat. J. Gastroenterol. Hepatol. 11:1996;625.
24. Ben-Maimon C. S., Burke J. F., Besarab A., Jarrell B. E., Francos G. C., Moyer S. S. Evidence against chronic progressive cyclosporine nephrotoxicity. Transplant. Proc. 23:1991;1260.
25. Klintmalm G. B. G., Iwatsuki S., Starzl T. E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation. 32:1981;489.
26. Harihari Y., Sanjo K., Idezuki Y. Cyclosporine hepatoxicity and cold ischemia liver damage. Transplant. Proc. 24:1992;1984.
27. Viebahn R., Metzdorf B., de Groot H., Lauchart W. Simulation of hypoxic and preservation injury in human hepatocyte cultures: Influence of FK 506 and cyclosporine. Transplant. Proc. 25:1993;2691.